Stock Trading History of Burgoon Richard Jr

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Burgoon Richard Jr since year 2005. The trader's CIK number is 1289797. At the time of this reporting, Burgoon Richard Jr is the Chief Executive Officer of Aeolus Pharmaceuticals, Inc. (stock ticker symbol AOLS).

Stock purchases, sales, and option exercises reported by *Burgoon Richard Jr* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2006-09-29	AOLS	Aeolus Pharmaceuticals, Inc.	Option Exercise	20,833	1.00	20,833
2006-03-31	AOLS	Aeolus Pharmaceuticals, Inc.	Option Exercise	20,833	1.00	20,833
2005-12-30	AOLS	Aeolus Pharmaceuticals, Inc.	Option Exercise	20,833	1.00	20,833
2006-07-10	AOLS	Aeolus Pharmaceuticals, Inc.	Option Exercise	20,833	1.00	20,833
2005-09-02	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	1,600	.92	1,480
2005-08-30	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	1,250	.80	1,000
2005-08-29	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	400	.85	340
2005-08-23	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	200	.92	184
2005-08-17	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	300	.97	291
2005-08-12	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	300	.97	291
2005-08-01	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	300	.97	291
2005-07-29	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	400	.97	388
2005-07-25	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	100	.97	97
2005-07-22	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	200	.97	194
2005-07-20	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	200	.97	194
2005-07-21	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	300	.97	291
2005-07-19	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	400	.97	388
2005-07-14	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	600	.97	582
2005-04-20	AOLS	Aeolus Pharmaceuticals, Inc.	Purchase	6,000	.54	3,270

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Burgoon Richard Jr (Chief Executive Officer of Aeolus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.